Vancomycin-resistant Enterococcus faecium meningitis in adults: Case series and review of the literature

References

• Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, . NHSN annual update: antimicrobial- resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008;29:996–1011.
   PubMed Web of Science ®Google Scholar
• Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, . Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993;328:21–8.
   Web of Science ®Google Scholar
• Pintado V, Cabellos C, Moreno S, Meseguer MA, Ayats J, Viladrich PF. Enterococcal meningitis: a clinical study of 39 cases and review of the literature. Medicine (Baltimore) 2003;82:346–64.
   PubMed Web of Science ®Google Scholar
• Tush GM, Huneycutt S, Phillips A, Ward JD. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection. Clin Infect Dis 1998;26:1460–1.
   PubMed Web of Science ®Google Scholar
• Sarma PS, Mohanty S. Mixed meningitis: association of Acinetobacter calcoaceticus var. lwoffi and Streptococcus faecium. Postgrad Med J 1995;71:295–6.
   PubMed Web of Science ®Google Scholar
• Koc Y, Snydman DR, Schenkein DS, Miller KB. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant 1998;22:207–9.
   PubMed Web of Science ®Google Scholar
• Dever LL, Smith SM, Dejesus D, Masurekar M, Patel D, Kaminski ZC, . Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases. Microb Drug Resist 1996;2:407–13.
   PubMed Web of Science ®Google Scholar
• Zeana C, Kubin CJ, Della-Latta P, Hammer SM. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin Infect Dis 2001;33:477–82.
   PubMed Web of Science ®Google Scholar
• Tan TY, Pitman I, Penrose-Stevens A, Simpson BA, Flanagan PG. Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature. J Infect 2000;41:95–7.
   PubMed Web of Science ®Google Scholar
• Williamson JC, Glazier SS, Peacock JE Jr.Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/dalfopristin. Clin Neurol Neurosurg 2002;104:54–6.
   PubMed Web of Science ®Google Scholar
• Shaikh ZH, Peloquin CA, Ericsson CD. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis 2001;33:375–9.
   PubMedGoogle Scholar
• Garey KW, Tesoro E, Muggia V, Pasquier O, Rodvold KA. Cerebrospinal fluid concentrations of quinupristin–dalfopristin in a patient with vancomycin-resistant Enterococcus faecium [correction of faecalis] ventriculitis. Pharmacotherapy 2001;21:748–50.
   PubMed Web of Science ®Google Scholar
• Kanchanapoom T, Koirala J, Goodrich J, Agamah E, Khardori N. Treatment of central nervous system infection by vancomycin-resistant Enterococcus faecium. Diagn Microbiol Infect Dis 2003;45:213–5.
   PubMed Web of Science ®Google Scholar
• Scapellato PG, Ormazabal C, Scapellato JL, Bottaro EG. Meningitis due to vancomycin-resistant Enterococcus faecium successfully treated with combined intravenous and intraventricular chloramphenicol. J Clin Microbiol 2005; 43:3578–9.
   PubMed Web of Science ®Google Scholar
• Mizell KN, Carter JE. Vancomycin-resistant Enterococcus faecium meningitis successfully treated with linezolid. South Med J 2008;101:569–70.
   PubMed Web of Science ®Google Scholar
• Steinmetz MP, Vogelbaum MA, De Georgia MA, Andrefsky JC, Isada C. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid: case report and review of the literature. Crit Care Med 2001;29:2383–5.
   PubMed Web of Science ®Google Scholar
• Tsai TN, Wu CP, Peng MY, Giian CF, Lee SY, Lu JJ. Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis. Int J Clin Pract 2006; 60:740–1.
   PubMed Web of Science ®Google Scholar
• Le J, Bookstaver PB, Rudisill CN, Hashem MG, Iqbal R, James CL, . Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy. Ann Pharmacother 2010; 44:2001–6.
   PubMed Web of Science ®Google Scholar
• Hachem R, Afif C, Gokaslan Z, Raad I. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis 2001;20:432–4.
   PubMed Web of Science ®Google Scholar
• Inan D, Gunseren F, Colak D, Saba R, Kazan S, Mamikoglu L. First confirmed case of vancomycin-resistant Enterococcus faecium meningitis in Turkey: case report and literature review. J Chemother 2004;16:608–11.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Ninth tenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009.
   Google Scholar
• Eliopoulos GM, Wennersten CB. Antimicrobial activity of quinupristin–dalfopristin combined with other antibiotics against vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002;46:1319–24.
   PubMed Web of Science ®Google Scholar
• Bain KT, Wittbrodt ET. Linezolid for the treatment of resistant Gram-positive cocci. Ann Pharmacother 2001;35: 566–75.
   PubMed Web of Science ®Google Scholar
• Webster DP, Griffiths S, Bowler IC. Failure of linezolid therapy for post-neurosurgical meningitis due to Enterococcus faecium. J Antimicrob Chemother 2009;63:622–3.
   PubMed Web of Science ®Google Scholar
• Scheetz MH, Knechtel SA, Malczynski M, Postelnick MJ, Qi C. Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption. Antimicrob Agents Chemother 2008;52:2256–9.
   PubMed Web of Science ®Google Scholar
• Gerber P, Stucki A, Acosta F, Cottagnoud M, Cottagnoud P. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother 2006;57:720–3.
   PubMed Web of Science ®Google Scholar
• Cilli F, Aydemir S, Tunger A. In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci. J Chemother 2006;18:27–32.
   PubMed Web of Science ®Google Scholar
• Pankey G, Ashcraft D, Patel N. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob Agents Chemother 2005;49:5166–8.
   PubMed Web of Science ®Google Scholar
• Caron F, Kitzis MD, Gutmann L, Cremieux AC, Maziere B, Vallois JM, . Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium. Antimicrob Agents Chemother 1992;36:2611–6.
   PubMed Web of Science ®Google Scholar
• Sakoulas G, Bayer AS, Pogliano J, Tsuji BT, Yang SJ, Mishra NN, . Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 2012;56:838–44.
   PubMed Web of Science ®Google Scholar
• Jaspan HB, Brothers AW, Campbell AJ, McGuire JK, Browd SR, Manley TJ, . Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J 2010;29: 379–81.
   PubMed Web of Science ®Google Scholar
• Gill CJ, Murphy MA, Hamer DH. Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid. J Infect 2002;45:129–32.
   PubMed Web of Science ®Google Scholar
• Dandache P, Nicolau DP, Sakoulas G. Tigecycline for the treatment of multidrug-resistant Klebsiella pneumoniae meningitis. Infect Dis Clin Pract 2009;17:66–8.
   Google Scholar